Strengthening Families & Communities LLC’s Supernus Pharmaceuticals SUPN Stock Holding History

Strengthening Families & Communities LLC’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$279	Buy	+6	New	+$288	﹤0.01%	811

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Strengthening Families & Communities LLC's SUPN Position: Q2 2026 in Review

Strengthening Families & Communities LLC opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 6 shares worth $279. The stake represents ﹤0.01% of the portfolio and ranks #811 among its holdings.

162 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Strengthening Families & Communities LLC held 6 shares of Supernus Pharmaceuticals worth $279 as of Q2 2026.
Supernus Pharmaceuticals was a new Strengthening Families & Communities LLC position in Q2 2026.
Supernus Pharmaceuticals made up ﹤0.01% of Strengthening Families & Communities LLC's portfolio in Q2 2026, its #811 holding.
162 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q2 2026, filed 11 Aug 2026.